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THE PREVALENCE OF PATELLOFEMORAL OSTEOARTHRITIS: A
SYSTEMATIC REVIEW
S. Kobayashi, E. Pappas, M. Fransen, K. Refshauge, M. Simic. Univ. of
Sydney, Sydney, Australia
Purpose: The patellofemoral joint has distinct structural, bio-
mechanical and clinical differences from the medial and lateral tibio-
femoral joints. However, it has not received adequate attention in
research into knee osteoarthritis (OA), where it is rarely considered
independently of the tibiofemoral joint. Previous reviews have inves-
tigated the prevalence of knee OA but did not report the compartmental
distribution of OA in the knee joint. To date, there has been no synthesis
of studies evaluating the prevalence of patellofemoral OA. This sys-
tematic review aims to determine the prevalence of radiographically
conﬁrmed patellofemoral OA amongst the general population and
people with knee OA.
Methods: A search strategy was established, using terms associated
with “patellofemoral OA”, “prevalence” and “clinical features”. These
terms were used to search through Medline, EMBASE, CINAHL, SCOPUS,
AMED and Web of Sciences (all databases) with no language restriction
from database inception to August 2014. Duplicates were excluded, and
two independent reviewers screened for eligibility. Studies were
included if they reported prevalence of compartmental patterns of
radiographic OA (patellofemoral and tibiofemoral OA) in a community
or in a cohort of people with knee OA. Diagnosis of OA had to be con-
ducted using a radiograph in accordance with American College of
Rheumatology recommendations for the diagnosis of OA. Studies were
excluded if they evaluated a targeted sample (e.g. occupation-speciﬁc
participants) or repeated already reported data from the same cohorts.
Data were extracted from studies that met the eligibility criteria.
Prevalence numbers of patellofemoral OA were collated and quantita-
tively analysed.
Results: The search yielded 3834 records. After the initial screen, 126
full-text articles were assessed by two independent reviewers. The
inclusion criteria were met by 23 studies that reported data on 10749
participants aged 20 years or more for the presence of radiographic
knee OA. Whilst radiographic criteria were used by individual studies,
their inclusion criteria for participant eligibility were mixed, varying
from population and community-based samples (n¼9 studies) to
cohorts where all participants were experiencing knee pain (n¼14
studies). Amongst the 9 studies that included samples from the general
population aged 20 years or more, radiographic patellofemoral OA
prevalence was present in 30.6% (1294/4230 participants). Findings
from the 14 remaining studies that included samples with clinical and
radiographic signs of OA identiﬁed patellofemoral OA prevalence to be
25.2% (1530/6067 participants) amongst participants aged 30 years or
more.
Conclusions: This systematic review is the ﬁrst to report the prevalence
of patellofemoral OA amongst the general population as well as
amongst people with knee pain. Findings from this review conﬁrm the
substantial prevalence of patellofemoral OA, demonstrating the need to
consider the patellofemoral joint in research and clinical settings.
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DETERMINANTS OF REDUCED WORK PRODUCTIVITY AMONG
PEOPLE WITH CHRONIC KNEE PAIN: A CROSS SECTIONAL SURVEY
M. Agaliotis y, M.G. Mackey y, R. Heard y, S. Jan z, M. Fransen y. yUniv. of
Sydney, Sydney, NSW, Australia; z The George Inst. for Global Hlth., Sydney,
NSW, Australia
Purpose: The aims of this study were to evaluate the burden and
explore potential determinants of reduced work productivity among
people with chronic knee pain.
Methods: A survey containing several validated measures of absen-
teeism, presenteeism and work transitions as well as individual, disease
and work-related demographics was mailed to 496 people who had
completed participation in the Long-term Evaluation of Glucosamine
Sulfate (LEGS) study.
Results: A total of 296 (60%) people provided a completed survey with
129 currently in paid employment. Only six (5%) reported absenteeism
in the past twomonths, however 63 (49%) reported presenteeism over a
seven day period and 31 (24%) reported making one or more work
transitions in the last six months due to knee problems. In multivariate
analysis, presenteeism was associated with moderate to severe kneepain (3/10) (odds ratio (OR) 2.77, 95% CI 1.30 - 5.8) and reporting
problems with other joints (OR 2.32, 95% CI 1.04 - 5.17) while job
instability reduced the likelihood (OR 0.40, 95% CI 0.19 - 0.86). Reporting
one or more work transitions was associated with moderate to severe
knee pain (OR 4.09, 95% CI 1.53 - 10.95), a high co-morbidity score (OR
4.44, 95% CI: 1.02 - 19.32) and low co-worker support (OR 2.79, 95% CI
1.04 - 7.46) while having an occupation involving sitting >30% of the
working day reduced the likelihood (OR 0.35, 95% CI 0.12 - 0.97).
Conclusions: This survey demonstrates the high prevalence of reduced
work productivity among people with chronic knee pain. Allowing
access to sitting and promoting positive afﬁliations between co-work-
ers are likely to provide an enabling workplace environment for these
workers.
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INCIDENCE AND PREVALENCE OF TOTAL JOINT REPLACEMENTS DUE
TO OSTEOARTHRITIS IN THE ELDERLY: RISK FACTORS AND FACTORS
ASSOCIATED WITH LATE LIFE PREVALENCE. THE AGES-REYKJAVIK
STUDY
H. Jonsson y,z, S. Olafsdottir y, S. Sigurdardottir y, T. Aspelund x,z,
G. Eiriksdottir x, S. Sigurdsson x, T.B. Harris x, L. Launer x,
V. Gudnason x,z. y Landspitalinn Univ. Hosp., Reykjavik, Iceland; zUniv. of
Iceland, Reykjavik, Iceland; x Icelandic Heart Association, Kopavogur,
Iceland; kNatl. Inst. on Aging, Bethesda, MD, USA
Purpose:To analyze factors associated with late-life prevalence and risk
factors for incidence of total joint replacements (TJRs) due to osteo-
arthritis in a population based cohort.
Methods:After exclusion of those with inﬂammatory arthritis and
fractures as causes of TJR, 5170 participants in the AGES-Reykjavik Study
(mean age 76.4(6), 58% females) were included for osteoarthritis
studies. 3133 of them had a follow-up visit 5 years later. TJRs were
registered from CT scans at both visits.
Results:The prevalence of having at least one joint replacement oper-
ation due to OAwas 13.6% and the yearly incidencewas 1.4%/year during
the ﬁve-year follow-up. Education, occupation classes and physical
activity showed no association. Factors positively associated with late
life prevalence of TJR included BMI (OR 1.08(1.06-1.11), p¼1.7x10-17 per
unit), hand OA severity (OR 1.19(1.13-1.27), p¼3.9x10-9 per severity unit
on a 0-4 scale), female gender, ﬁnger length ratio and spine BMD.
Risk factors for TKRs in the incidence group were knee symptoms at
initial visit (OR 6.77(3.87-11.85), p¼2.1x10-11), prior TKR in the con-
tralateral joint (OR 4.94(2.42-7.71), p¼7.8x10-7) and BMI (OR 1.13(1.08-
1.19), p¼9.0x10-8). Predictors for THR were hip symptoms (OR
2.92(1.93-4.41), p¼3.9x10-7) and prior THR (OR 3.56(2.04-6.22),
p¼8.3x10-6). Much stronger associations were seen for TKR than for
THR with discriminatory analysis showing an AUC 0.71 for late life
prevalence and 0.84 for the incidence.
Conclusions:This study illustrates the importance of the different
information expressed by late life prevalence vs. incidence on the fac-
tors associated with severe osteoarthritis of the knee and hip. The
observation that prior TJR is a risk factor for subsequent TJR in the
contralateral joint has not been described previously. The high power
predictions for TKR suggest that a predictive model may be feasible,
particularly if it can be extended by the addition of further predictive
variables, perhaps through genetic, biomarker or imaging data.
Genetics, Genomics and Epigenetics
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THE DOT1L PROTEIN AND GENE NETWORK IN CHONDROCYTES
IDENTIFIES H3K79 HISTONE METHYLATION AS A KEY REGULATOR
OF WNT AND OTHER GROWTH FACTOR CASCADES
S. Monteagudo, F. Cailotto, R.J. Lories. KU Leuven, Leuven, Belgium
Purpose: DOT1L is the only known H3K79 histone methyltransferase
and has been linked to epigenetic regulation of the Wingless-like (Wnt)
signaling pathway. Genome-wide association and functional studies
identiﬁed the DOT1L gene to be associated with cartilage thickness and
hip osteoarthritis (OA) and showed an interaction of DOT1L with can-
onical Wnt signaling. Here, we further investigated the biology of
DOT1L in cartilage health and disease. Speciﬁcally, our objective was to
deﬁne the transcriptional complexes and transcriptome associated with
DOT1L in articular cartilage, and to link these DOT1L targets and
interactors with the molecular characteristics of the articular
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A190chondrocyte during the loss of phenotype in a dedifferentiation setup.
Finally, we aimed for a translational validation of our data in cartilage
samples from OA patients.
Methods: Human articular chondrocytes (hACs) stimulated or not with
LiCl were used to carefully map the presence or absence of DOT1L
protein complexes suggested earlier in leukemia cells, using a series of
speciﬁc immunoprecipitation experiments. To elucidate the transcrip-
tional network of Dot1l, we performed a microarray of hACs from 5
non-OA fracture patients treated with a speciﬁc DOT1L inhibitor
(EPZ5676) or vehicle control. The differentially expressed genes were
explored with the limma package. String-DB and Panther were used for
gene network analyses. Based on the microarray analysis, selected
genes were conﬁrmed by quantitative PCR. To establish the role of
DOT1L in the maintenance of hACs phenotype, hACs were cultured in
monolayer in the presence or absence of EPZ5676, and RNA and protein
were isolated at serial passages (P0 to P5). We analyzed by quantitative
PCR the gene expression of known genes important for chondrocyte
biology and/or genes that appeared in the microarray of DOT1L inhib-
ition. Activation of the Wnt canonical and non-canonical signaling
cascades was analyzed by Western blot. For translational validation we
analyzed the differential gene expression proﬁle of damaged as com-
pared to intact cartilage areas within the same joint of patients with hip
OA.
Results: The presence of different DOT1L elongation complexes was
conﬁrmed in hACs. The CoIP experiments revealed that DOT1L interacts
directly with ENL, AF10 and active beta-catenin (more strongly when
cells were treated with LiCl to stabilize beta-catenin) and with AF4 and
AF5 (only with cells were treated with LiCl). The formation of these
complexes was disrupted when DOT1L was inhibited. In the microarray,
1937 genes signiﬁcantly changed (p<0.05) in DOT1L inhibited samples
compared to vehicle treated samples (1048 genes were down-regu-
lated, 889 up-regulated). In EPZ5676 treated samples, chondrocyte
differentiation-associated genes, such as ACAN, RGS5, GDF10 and LOXL2
were down-regulated; OA-related genes, such as MMP1, CCL7, CCL8 and
GPNMB were up-regulated; and WNT target genes, ligands and antag-
onists such as LEF1, WNT5A and DKK1 were signiﬁcantly up-regulated.
In the de-differentiation experiment, in vitro expanded hACs showed
progressive changes in gene expression. Genes involved in relevant
pathways for cartilage biology such as the WNT, NOTCH and BMP
pathways exhibited signiﬁcant changes that were highly accentuated by
DOT1L inhibition. We successfully validated these targets of interest in
samples from patients with OA condition.
Conclusions: Our transcriptomic, protein and gene interaction
approach provides novel insights into the DOT1L molecular network
and its putative role in osteoarthritis and cartilage. These data further
support an important role for DOT1L in joint homeostasis as a key
regulator of WNT signaling and other growth factor cascades in the
joint.
294
DISCRIMINATING BETWEEN PUTATIVE EPIGENETIC OSTEOARTHRITIS
DISEASE DRIVERS AND SHEER MARKERS
W. den Hollander, Y.F. Ramos, N. Bomer, S. Elzinga, R. van der Breggen,
N. Lakenberg, W.J. de Dijcker, E.H. Suchiman, B.J. Duijnisveld,
S. B€ohringer, J.J. Houwing-Duistermaat, E.P. Slagboom, S.D. Bos,
R.G. Nelissen, I. Meulenbelt. LUMC, Leiden, Netherlands
Purpose: It has become increasingly clear that DNA methylation is
eminently involved in osteoarthritis (OA) pathology, as reﬂected by the
large number of differentially methylated CpGs that have been reported
between healthy, preserved and lesioned articular cartilage. However,
as with the vast number of differentially expressed genes observed in
OA affected articular cartilage, it remains unclear whether these
observed differences are either cause or consequence of the disease. By
combining genome wide methylation, expression and single nucleotide
polymorphism (SNP) datasets we aim to achieve directional insight in
the observed epigenetic and transcriptional changes in OA affected
articular cartilage and report on putative protective and susceptibility
loci.
Methods: Transcriptional activity of CpGs (t-CpGs) was assessed using
genome wide gene expression and DNA methylation data of respec-
tively 33 and 31 pairs of preserved and lesioned articular cartilage.
Disease responsive t-CpGs were identiﬁed by means of differential
methylation between preserved and lesioned cartilage. Additionally, we
addressed proximal SNPs near the OA responsive t-CpGs. Statisticalanalyses were corrected for age, sex, joint and technical covariates,
while a random effect was included to correct for possible correlations
between paired samples.
Results: Of the 9838 transcribed genes in articular cartilage, 2324 cor-
related signiﬁcantly with the methylation status of 3748 t-CpGs , both
canonically negative (N¼1741) as positive (N¼2007) correlations were
observed. Hypomethylation and hypermethylation (FDR<0.05,
jDbj>0.05) were observed for 92 and 59 t-CpGs, respectively, covering
117 unique genes. Signiﬁcant enrichment for developmental and ECM
maintenance pathways was observed, indicating possible reactivation
of endochondral ossiﬁcation. Finally, we observed 11 and 84 OA carti-
lage relevant genes of which, respectively, methylation and expression
is additionally affected by genetic variation. Among others, we here
present the potential disease driving genes ROR2 and CAV1 (ﬁgure 1), as
reﬂected by differential expression between preserved and lesioned
cartilage and, moreover, epigenetic and genetic transcriptional
consequences.
Conclusions: We have shown that OA related epigenetic differences
need to be integrated with other sources of molecular data, such as
genomic and transcriptomic, to enhance our understanding of the
pathophysiological processes of OA. Furthermore, by integration of
multiple layers of genome wide data we have identiﬁed genes, such as
ROR2 and CAV1, which are likely functionally involved in OA patho-
physiology, as opposed to sheer consequence. Although targeting DNA
methylation seems unlikely to stand at the basis for developing treat-
ments, it serves to deepen our understanding of the complex tran-
scriptomic changes in OA affected articular cartilage. Finally, our results
comprise an important step in understanding the reported widespread
epigenetic changes occurring in OA affected articular cartilage.
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PROBING THE ARTICULAR CARTILAGE TRANSCRIPTOME FOR
GENETIC OSTEOARTHRITIS SUSCEPTIBLITY
W. den Hollander, I. Pulyakhina, N. Bomer, Y.F. Ramos,
R. van der Breggen, S. Bos, P-B. A. 't Hoen, E.P. Slagboom, R.G. Nelissen,
I. Meulenbelt. LUMC, Leiden, Netherlands
Purpose: Genome wide approaches have supplied the osteoarthritis
(OA) ﬁeld with robust susceptibility loci. A number of these risk alleles
act by affecting transcriptional regulation of genes in cis, particularly in
disease relevant tissues. For OA this has been demonstrated previously
for e.g. ALDH1A2, DIO2 and GDF5 by a marked allelic imbalance (AI) in
articular cartilage, a transcriptional phenomenon in which the two
alleles in heterozygous carriers are expressed to unequal extent. Here,
we set out to address the entire articular cartilage transcriptome by
means of RNA sequencing and have assessed AI in all cartilage
expressed genes.
Methods: From 21 patients (6 hips, 15 knees) preserved and lesioned
cartilage were collected. Additionally, from, respectively, 21 (14 hip, 7
knee) and 5 (2 hip, 3 knee) patients, we collected preserved or lesioned
cartilage only. RNA sequencing resulted in 10 million paired-end 100x2
bp long reads per sample. AI was performed on SNPs called using
SNVMix2 with minimum coverage of 25. To avoid rare genetic variants,
only SNPs that were observed in >9 samples were analysed. Fur-
thermore, non-dbSNP A>G SNPs were removed as potential RNA-edit-
ing events. Differential gene expression between preserved and paired
lesioned cartilage was performed using the edgeR package.
Results: We assessed AI in 15216 heterozygous coding SNPs of the
articular cartilage transcriptome and observed that 1175 SNPs tagged AI
of 493 unique genes (FDR<0.05, 0.1<minor/major allele ratio<0.4).
